...
首页> 外文期刊>The International journal of biological markers >Cutaneous metastasis as a primary presentation of a pulmonary enteric adenocarcinoma
【24h】

Cutaneous metastasis as a primary presentation of a pulmonary enteric adenocarcinoma

机译:皮肤转移作为肺肠腺癌的主要呈递

获取原文
           

摘要

Background: Primary pulmonary enteric adenocarcinoma (PEAC) is a rare non-small cell lung cancer subtype sharing morphologic and immunohistochemical features with colorectal adenocarcinoma. Given the frequency of lung metastases in colorectal cancer, the differential diagnosis of PEAC according to routine morphological and immunohistochemical findings may be difficult. Genome sequence by next-generation sequencing has recently introduced new perspectives to better define the diagnosis and tumor sensitivity to treatments, while the rarity of this subtype of cancer still limits the current knowledge of its molecular features and provides no information to address patients to tailored therapies. Methods: We diagnosed a rare case of subcutaneous metastasis as a first symptom of a PEAC. Formalin-fixed paraffin-embedded samples of the primary tumor and subcutaneous metastases were examined by immunohistochemistry, and subsequently by targeted next-generation sequencing analysis. Results: Morphological and immunohistochemical findings suggested a rare case of metastatic pulmonary adenocarcinoma with enteric aspects. Next-generation sequencing analysis performed on both the primary tumor sample and the cutaneous lesion identified two pathogenic variants on CDKN2A and KRAS in both of them. However, the metastasis showed two additional pathogenic mutations located in SMAD4 and FLT3 genes. Conclusions: We describe for the first time an extensive molecular analysis on a rare case of PEAC with an unusual cutaneous metastasis. Our observation suggests that a specific pattern of mutations is harbored in this neoplasm, and that additional molecular studies may provide further information to identify prognostic and hopefully predictive genes of response to treatment.
机译:背景:初级肺肠腺癌(PEAC)是一种罕见的非小细胞肺癌亚型,分享与结肠直肠腺癌的形态学和免疫组化特征。鉴于结直肠癌中肺转移的频率,根据常规形态和免疫组织化学发现的PEAC的差异诊断可能是困难的。通过下一代测序的基因组序列最近引入了新的视角,以更好地定义对治疗的诊断和肿瘤敏感性,而这种癌症亚型的稀有性仍然限制了其分子特征的目前的知识,并没有提供给患者定制患者的目前的知识。方法:诊断出一种罕见的皮下转移作为PEAC的第一个症状。通过免疫组织化学检查福尔马林固定的原发性肿瘤和皮下转移的样品,随后通过靶向的下一代测序分析检查。结果:形态学和免疫组织化学研究结果表明,肠道方面的转移性肺腺癌的罕见案例。对初级肿瘤样品和皮肤病变进行的下一代测序分析确定了两种CDKN2A和KRAS上的两种致病变体。然而,转移显示出位于Smad4和FLT3基因中的另外两种致病性突变。结论:我们首次描述了对具有异常皮肤转移的PEAC罕见案例的广泛分子分析。我们的观察结果表明,在该肿瘤中患有特定的突变模式,并且额外的分子研究可以提供进一步的信息以鉴定对治疗反应的预后和希望预测基因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号